371 related articles for article (PubMed ID: 8118011)
21. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
22. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
23. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
Ganu UK; Khandalekar DD; Gokhale SV
Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
[TBL] [Abstract][Full Text] [Related]
24. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
Kamath NS; Chitnis MP
Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S
J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113
[TBL] [Abstract][Full Text] [Related]
26. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance studies on intraspecific hybridomas.
Pályi I; Turi G; Szikla K; Dallmann L
Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
[TBL] [Abstract][Full Text] [Related]
28. Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents.
Pasquinelli P; Petrini M; Mattii L; Galimberti S; Saviozzi M; Malvaldi G
J Environ Pathol Toxicol Oncol; 1993; 12(4):193-7. PubMed ID: 8189374
[TBL] [Abstract][Full Text] [Related]
29. [The effect of thymalin on the count of large granular lymphocytes in the peripheral blood of mice with leukemia P388].
Potapov IuN; Khaleev DV; Krutova TV; Pashkova VS
Izv Akad Nauk SSSR Biol; 1991; (1):133-5. PubMed ID: 1856357
[TBL] [Abstract][Full Text] [Related]
30. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
Chitnis MP; Viladkar AB; Juvekar AS
Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
33. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
Inaba M; Maruyama E
Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
35. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
Sokolova IS; Riabokon' NA; Chernov VA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (5):660-5. PubMed ID: 2584530
[TBL] [Abstract][Full Text] [Related]
38. [Changes in glutathione-S-transferase activity during induction of resistance of leukemia P 388 and Ehrlich ascitic tumor cells to doxorubicin].
Donenko FV; Kabieva AO; Borovkova NB; Moroz LV
Biull Eksp Biol Med; 1991 Aug; 112(8):188-90. PubMed ID: 1786387
[TBL] [Abstract][Full Text] [Related]
39. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
